These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 20035517

  • 1. Use of thromboelastography PlateletMapping to monitor antithrombotic therapy in a patient with Budd-Chiari syndrome.
    James K, Bertoja E, O'Beirne J, Mallett S.
    Liver Transpl; 2010 Jan; 16(1):38-41. PubMed ID: 20035517
    [Abstract] [Full Text] [Related]

  • 2. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
    Valgimigli M, Campo G, de Cesare N, Meliga E, Vranckx P, Furgieri A, Angiolillo DJ, Sabatè M, Hamon M, Repetto A, Colangelo S, Brugaletta S, Parrinello G, Percoco G, Ferrari R, Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators.
    Circulation; 2009 Jun 30; 119(25):3215-22. PubMed ID: 19528337
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology.
    Chinnakotla S, Klintmalm GB, Kim P, Tomiyama K, Klintmalm E, Davis GL, Trotter JF, Saad R, Landaverde C, Levy MF, Goldstein RM, Stone MJ.
    Transplantation; 2011 Aug 15; 92(3):341-5. PubMed ID: 21659946
    [Abstract] [Full Text] [Related]

  • 4. The Janus face of thromboprophylaxis in patients with high risk for both thrombosis and bleeding during intracranial surgery: report of five exemplary cases.
    Niemi T, Silvasti-Lundell M, Armstrong E, Hernesniemi J.
    Acta Neurochir (Wien); 2009 Oct 15; 151(10):1289-94. PubMed ID: 19513580
    [Abstract] [Full Text] [Related]

  • 5. [Budd-Chiari syndrome and TIPS--twelve years' experience].
    Safka V, Hůlek P, Krajina A, Dulícek P, Fejfar T, Jirkovský V, Pozler O, Vańásek T.
    Cas Lek Cesk; 2005 Oct 15; 144 Suppl 3():38-42. PubMed ID: 16335262
    [Abstract] [Full Text] [Related]

  • 6. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA.
    J Am Coll Cardiol; 2007 Feb 13; 49(6):657-66. PubMed ID: 17291930
    [Abstract] [Full Text] [Related]

  • 7. Platelet inhibition by increased tirofiban dosing during primary coronary angioplasty for ST elevation myocardial infarction.
    Kralisz P, Dobrzycki S, Nowak K, Kochman W, Gajewska-Bachórzewska H, Gugała K, Mezyński G, Prokopczuk P, Zuk J, Korecki J, Poniatowski B, Musiał W.
    Kardiol Pol; 2004 May 13; 60(5):459-67. PubMed ID: 15247961
    [Abstract] [Full Text] [Related]

  • 8. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt.
    Kavanagh PM, Roberts J, Gibney R, Malone D, Hegarty J, McCormick PA.
    J Gastroenterol Hepatol; 2004 Oct 13; 19(10):1135-9. PubMed ID: 15377290
    [Abstract] [Full Text] [Related]

  • 9. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S, Hoffmeister HM, Bode C.
    Herz; 2008 Jun 13; 33(4):244-53. PubMed ID: 18581073
    [Abstract] [Full Text] [Related]

  • 10. Antiplatelet intervention in acute coronary syndrome.
    Arora RR, Rai F.
    Am J Ther; 2009 Jun 13; 16(5):e29-40. PubMed ID: 19092648
    [Abstract] [Full Text] [Related]

  • 11. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K.
    Semin Thromb Hemost; 1997 Jun 13; 23(4):349-56. PubMed ID: 9263351
    [Abstract] [Full Text] [Related]

  • 12. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL, Malinin AI, Jerome SD, Lowry DR, Morgan AW, Sane DC, Tanguay JF, Steinhubl SR, O'connor CM.
    Am Heart J; 2003 Oct 13; 146(4):713-20. PubMed ID: 14564328
    [Abstract] [Full Text] [Related]

  • 13. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
    Opitz T, Buchwald AB, Lorf T, Awuah D, Ramadori G, Nolte W.
    Z Gastroenterol; 2003 May 13; 41(5):413-8. PubMed ID: 12772054
    [Abstract] [Full Text] [Related]

  • 14. Superior sagittal sinus thrombosis and Budd-Chiari syndrome due to paroxysmal nocturnal hemoglobinuria managed with transjugular intrahepatic portosystemic shunt: a case report.
    Sharma A, Itha S, Baijal SS, Gupta R, Sonkar A, Aggarwal R.
    Trop Gastroenterol; 2005 May 13; 26(3):146-8. PubMed ID: 16512467
    [Abstract] [Full Text] [Related]

  • 15. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
    Ganger DR, Klapman JB, McDonald V, Matalon TA, Kaur S, Rosenblate H, Kane R, Saker M, Jensen DM.
    Am J Gastroenterol; 1999 Mar 13; 94(3):603-8. PubMed ID: 10086638
    [Abstract] [Full Text] [Related]

  • 16. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 13; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 17. Current perspectives in the treatment of thrombotic disorders.
    Drouet L, Caen JP.
    Semin Thromb Hemost; 1989 Apr 13; 15(2):111-22. PubMed ID: 2665082
    [Abstract] [Full Text] [Related]

  • 18. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
    Kaku S, Kawasaki T, Hisamichi N, Sakai Y, Taniuchi Y, Inagaki O, Yano S, Suzuki K, Terazaki C, Masuho Y, Satoh N, Takenaka T, Yanagi K, Ohshima N.
    Thromb Haemost; 1996 Apr 13; 75(4):679-84. PubMed ID: 8743199
    [Abstract] [Full Text] [Related]

  • 19. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP.
    Eur J Gastroenterol Hepatol; 2006 Nov 13; 18(11):1151-4. PubMed ID: 17033433
    [Abstract] [Full Text] [Related]

  • 20. Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?
    Swallow RA, Agarwala RA, Dawkins KD, Curzen NP.
    Platelets; 2006 Sep 13; 17(6):385-92. PubMed ID: 16973499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.